AG
SWTX
Artal Group’s SpringWorks Therapeutics SWTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,313,026
| Closed | -$49.5M | – | 86 |
|
|
2024
Q2 | $49.5M | Sell |
1,313,026
-102,322
| -7% | -$3.85M | 1.26% | 10 |
|
|
2024
Q1 | $69.7M | Sell |
1,415,348
-200,000
| -12% | -$9.84M | 1.77% | 8 |
|
|
2023
Q4 | $59M | Sell |
1,615,348
-201,272
| -11% | -$7.35M | 1.96% | 9 |
|
|
2023
Q3 | $42M | Hold |
1,816,620
| – | – | 1.8% | 11 |
|
|
2023
Q2 | $47.6M | Sell |
1,816,620
-729
| -0% | -$19.1K | 1.48% | 11 |
|
|
2023
Q1 | $46.8M | Sell |
1,817,349
-182,651
| -9% | -$4.7M | 2.78% | 10 |
|
|
2022
Q4 | $52M | Sell |
2,000,000
-53,403
| -3% | -$1.39M | 2.9% | 8 |
|
|
2022
Q3 | $58.6M | Buy |
2,053,403
+1,153,403
| +128% | +$32.9M | 2.5% | 8 |
|
|
2022
Q2 | $22.2M | Buy |
900,000
+50,000
| +6% | +$1.23M | 1.18% | 19 |
|
|
2022
Q1 | $48M | Hold |
850,000
| – | – | 2.01% | 14 |
|
|
2021
Q4 | $52.7M | Buy |
850,000
+250,000
| +42% | +$15.5M | 1.43% | 15 |
|
|
2021
Q3 | $38.1M | Buy |
600,000
+100,000
| +20% | +$6.34M | 0.85% | 25 |
|
|
2021
Q2 | $41.2M | Buy |
500,000
+100,000
| +25% | +$8.24M | 0.84% | 20 |
|
|
2021
Q1 | $29.4M | Sell |
400,000
-50,000
| -11% | -$3.68M | 0.52% | 36 |
|
|
2020
Q4 | $32.6M | Buy |
450,000
+165,000
| +58% | +$12M | 0.7% | 36 |
|
|
2020
Q3 | $13.6M | Sell |
285,000
-15,000
| -5% | -$715K | 0.33% | 56 |
|
|
2020
Q2 | $12.6M | Sell |
300,000
-50,000
| -14% | -$2.1M | 0.35% | 50 |
|
|
2020
Q1 | $9.45M | Hold |
350,000
| – | – | 0.4% | 43 |
|
|
2019
Q4 | $13.5M | Buy |
350,000
+41,474
| +13% | +$1.6M | 0.52% | 33 |
|
|
2019
Q3 | $6.69M | Buy |
+308,526
| New | +$6.69M | 0.27% | 53 |
|